Topic: Pharmaceutical

Orphan drugs hit 42% of new pharmaceuticals in Canada in 2016

Staff | June 27, 2018 / News

Assessing the impact of government policies, reforms on private payers

Sonya Felix | May 22, 2018 / News

From pharmacare to PMPRB reforms: The changing landscape for private plans

Sonya Felix | May 22, 2018 / News

Are benefits plan members being exposed to counterfeit pharmaceuticals?

Staff | February 14, 2018 / Health benefits

Canada second-highest spender on generic drugs among OECD countries: report

Staff | February 7, 2018 / News

Important questions to consider before making changes to a benefits plan

Martha Porado | February 2, 2018 / Health benefits

Generic drug deal hailed for price cuts of up to 40% for public, private plans

Staff | January 30, 2018 / News

The great pharmacare debate: An ‘overly simplistic’ solution or needed system rationalization?

Michael McKiernan | January 10, 2018 / News

A look at the five-year forecast for drug plan cost increases

Michael McKiernan | January 10, 2018 / News

‘The sky is not falling’ on drug costs

Jacqueline Louie | December 6, 2017 / News